Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 6, 2013

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Hepatocellular CarcinomaMetastasisInvasion
Interventions
DRUG

Colchicine

"Adjustment the dosage of colchicine during study:~The colchicine dosage will be changed when the hepatic reserved function of the participant changes from Child A to B according as following: 2 tablets after breakfast, 1 tablet after lunch and 2 tablets after dinner; continue 4 days and stop for 3 days (1 cycle); repeat this cycle until patients quit this trial. If the hepatic reserved function of the participant changes to Child C, colchicine will be stopped and participant receives regular follow-up only.If participant suffers from severe diarrhea, colchicine will be temporarily stopped. When the symptom of diarrhea subsides, colchicine will be given again but the dose will be reduced 0.5 mg/day."

Trial Locations (1)

807

Kaohsiung Medical University Hospital, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER

NCT01935700 - Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter